Oxycontin manufacturer Purdue Pharma files for bankruptcy; the rise in uninsured immigrants may be associated with fear of the Trump administration's crackdown on immigrants; an investigation has found that some cannabidiol (CBD) products are being spiked in Maryland.
Oxycontin manufacturer Purdue Pharma filed for bankruptcy protection Sunday night, amid growing lawsuits alleging their role in the United States’ significant opioid epidemic, according to Reuters. Purdue announced their tentative agreement to resolve lawsuits with 24 states, 5 US territories, and lead lawyers in more than 2000 cities and counties. The board of the opioid manufacturer met Sunday evening to approve their suspected bankruptcy filing, which will allow them to restructure under terms of a proposal to settle the expansive litigation. The Sackler family, who own Purdue Pharma, proposed to cede control in the settlement, as well as pay $3 billion in cash and an additional $1.5 billion or more through the sale of another company they own called Mundipharma.New statistics suggest that the Trump administration’s crackdown on immigrants has been to blame for rising number of people without health insurance in America, according to Axios. The Census Bureau reported that the number of insured in the United States rose by 1.9 million people in 2018, which was the first jump in almost a decade. Overall, 27.5 million people (8.5%) of the population lacked health coverage in 2018. Low-income populations, most significant in Hispanics, enrolled in Medicaid were exhibited as the contributing factor behind this rise in uninsured people. Uninsured Hispanics rose by 1.6 percentage points, with 18% lacking coverage.An investigation conducted by The Associated Press revealed that some people have been substituting cheap and dangerous street drugs for the cannabis extract cannabidiol (CBD). A reporter in Towson purchased 3 CBD vape pods and tested their efficacy in labs. Results showed that 1 contained synthetic marijuana, which has sent dozens of people nationwide to emergency rooms. Unlike CBD, which has no psychoactive properties, synthetic marijuana gives people an intense high. The Towson store’s co-owner removed the brand responsible for the synthetic marijuana spiking off their shelves, but CBD industry representatives acknowledged that spiking threats remain an issue.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More